Efficacy of Efalizumab in Psoriasis Patients Previously Treated with Tumour Necrosis Factor Blockers

Publisher： Karger

E-ISSN： 1421-9832|219|1|48-53

ISSN： 1018-8665

Source： Dermatology, Vol.219, Iss.1, 2009-04, pp. : 48-53

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of Etanercept in Psoriatic Patients Previously Treated with Infliximab

By  

Dermatology, Vol. 216, Iss. 4, 2008-01 ,pp. : 312-316

Karger

Access to resources Recommend Favorite

Visceral Leishmaniasis Infection in a Patient with Psoriasis Treated with Efalizumab

By  

Dermatology, Vol. 217, Iss. 4, 2008-09 ,pp. : 360-361

Karger

Access to resources Recommend Favorite

Generalised Pustular Psoriasis Induced by Cyclosporin A Withdrawal Responding to the Tumour Necrosis Factor Alpha Inhibitor Etanercept

By  

Dermatology, Vol. 205, Iss. 2, 2002-08 ,pp. : 213-216

Karger

Access to resources Recommend Favorite

Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study

By  

Dermatology, Vol. 225, Iss. 4, 2012-12 ,pp. : 312-319

Karger

Access to resources Recommend Favorite

Acrodermatitis Continua of Hallopeau Treated Successfully with Ustekinumab and Acitretin after Failure of Tumour Necrosis Factor Blockade and Anakinra

By  

Dermatology, Vol. 230, Iss. 2, 2014-11 ,pp. : 97-100

Karger

Access to resources Recommend Favorite